Universidad de León   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Leon Spain (1979)

Organization Overview

First Clinical Trial
2017
NCT04188158
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

COMPLEJO ASISTENCIAL UNIVERSITARIO DE LEON | Department of Physical Education and Sport (University of León, Spain) | Universidad de León

Active Ingredients

Drugs in Phase 3 Trials (2)

albendazole (Albenza) (1 trial)

ivermectin (stromectol) (1 trial)

Drugs in Phase 2 Trials (2)

capecitabine (xeloda) (1 trial)

oxaliplatin (eloxatin) (1 trial)

Drugs in Other Trials (2)

citrulline (1 trial)

nitrate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 6